Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole-metformin vs Letrozole-metformin-pioglitazone in CC-resistant PCOS
NCT02341703Phase 1Completed
- Sponsor
- Cairo University
- Start
- Feb 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pioglitazone in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Cairo University. Primary endpoint: Ovulation Rate at 6 months. Started Feb 2015; status: completed.
02
Drugs
pioglitazone
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on NCT02341703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341703.